C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1986
11/05/1986	EP0200344A2 Microorganisms as pesticides
11/05/1986	EP0200280A2 Oxidation resistant IL-2 muteins and their production, formulations containing such muteins, and DNA sequences and expression vectors coding for such muteins and corresponding transformed host cells
11/05/1986	EP0200231A2 Methods for preparing rabbit monoclonal antibodies, the cell lines used therein and the antibodies produced thereby
11/05/1986	EP0200107A2 Process for the immobilization of dissolved proteins
11/05/1986	EP0200090A2 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
11/05/1986	EP0200069A2 Continuous process for the enzymatic preparation of isomaltulose
11/05/1986	EP0199963A1 Ethosuximide assay tracers, immunogens and antibodies
11/05/1986	EP0199769A1 Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
11/05/1986	EP0199756A1 Monoclonal antibodies and their use
11/05/1986	EP0199755A1 Monoclonal antibodies and their use
11/05/1986	EP0199754A1 Monoclonal antibodies and their use
11/05/1986	EP0093436B1 Process for preparing permanent animal and human cell lines, and their use
11/05/1986	CN86102090A Procedure for obtaining, dna, rna, peptides, polypeptides, or proteins by recombinant dna techemiques
11/05/1986	CN86101066A Process for the production of new trifluoromethyl ketone substituted peptide derivatives
11/04/1986	US4621135 Oligo peptides having thymic humoral acitivity
11/04/1986	US4621073 Cyclic peptides having somatostatin activity
11/04/1986	US4621054 Biologically active substance, process for preparing the substance and immunoactive composition
11/04/1986	US4621053 Process for the production of human peptide hormones
11/04/1986	US4621052 Process for the production of human epidermal growth factor
11/04/1986	US4621050 Process for the production of human colony-stimulating factor
11/04/1986	CA1213579A1 Digoxigenin immunogens, antibodies, labeled conjugates, and related derivatives
11/04/1986	CA1213539A2 Bacterial polypeptide expression employing tryptophan promoter-operator
11/04/1986	CA1213538A1 Dna fragments coding for an immunogen peptide liable of inducing in vivo the synthesis of anti-poliovirus antibodies
11/04/1986	CA1213537A1 Polypeptide expression method
11/04/1986	CA1213521A1 Hydrophilic biopolymeric copolyelectrolytes, and biodegradable dressings comprising same
10/1986
10/29/1986	EP0199698A2 Process for the extraction and purification of proteins from culture media producing them
10/29/1986	EP0199644A1 Enzyme immobilisation
10/29/1986	EP0199586A2 Tumour-associated antigen
10/29/1986	EP0199568A2 Method for purifying interferon and composition of matter produced thereby
10/29/1986	EP0199480A2 Hepatitis A virus vaccines
10/29/1986	EP0199439A1 A method and probe for the detection of Actinobacillus Actinomycetemcomitans
10/29/1986	EP0199438A1 HTLV III Polypeptides
10/29/1986	EP0199405A2 Liquid detergents containing surfactant, proteolytic enzyme and boric acid
10/29/1986	EP0199404A2 Liquid detergents containing anionic surfactant, builder and proteolytic enzyme
10/29/1986	EP0199331A1 Pharmacologically active peptides
10/29/1986	EP0199301A1 Recombinant acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS
10/29/1986	EP0199223A2 Purification of immunoglobulin G
10/29/1986	EP0199196A2 Monoclonal antibody and method for the production thereof
10/29/1986	EP0199141A2 Monoclonal antibodies to human gastrointestinal cancer
10/29/1986	EP0199091A1 Process for the production of a herpes simplex virus type 2 specific antigen, suitable agents therefor and the use of this antigen
10/29/1986	EP0199042A1 Procainamide assay, tracers, immunogens and antibodies
10/29/1986	EP0199018A2 Expression in e.coli of hybrid polypeptides containing the growth hormone releasing factor sequence
10/29/1986	EP0198866A1 Monoclonal antibodies and their use
10/29/1986	EP0198828A1 Infectious bursal disease virus vaccine
10/28/1986	US4620012 Spirocyclic aminoacid derivatives, processes for their preparation, agents containing them and their use and new spirocyclic aminoacids as intermediates and processes for their preparation
10/28/1986	US4619989 Bone morphogenetic protein composition
10/28/1986	CA1213261A1 Polyethylenimine bound chromatographic packing
10/28/1986	CA1213234A1 Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
10/28/1986	CA1213226A1 Antibodies to human leucocyte interferon
10/28/1986	CA1213216A1 Purification method of human interferon
10/28/1986	CA1213214A1 Preparation of highly purified human antihemophilic factor
10/28/1986	CA1213213A1 Protein (pp.sub.1.sub.3), a process for enriching and isolating it and its use
10/28/1986	CA1213212A1 Protein (pp in17 xx), a process for concentrating and isolating it and its use
10/23/1986	WO1986006171A1 Test for rheumatic fever and monoclonal antibodies useful therefor
10/23/1986	WO1986006101A1 Novel procoagulant proteins
10/23/1986	WO1986006100A1 Human anti-inflammatory phospholipase inhibitor protein
10/23/1986	WO1986006099A1 EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
10/23/1986	WO1986006096A1 Von willebrand factor
10/23/1986	WO1986006080A1 gamma-INTERFERON COMPOSITION
10/23/1986	WO1986006079A1 Purified protein having angiogenic activity and methods of preparation
10/23/1986	WO1986006077A1 A method and a hybrid promoter for controlling exogenous gene transcription
10/23/1986	WO1986006076A1 Recombinant inhibin
10/23/1986	WO1986006075A1 Highly repetitive antigens of plasmodium falciparum
10/22/1986	EP0198745A1 Method for the microbiological synthesis of human serum albumin
10/22/1986	EP0198474A1 Hepatitis B surface antigen formed by recombinant DNA techniques, vaccines, diagnostics, cell lines and methods of forming same
10/22/1986	EP0198415A2 Alteration of the DNA sequence between the Shine-Dalgarno sequence and the start codon of the trp operon to increase the expression of proteins
10/22/1986	EP0198388A2 Enterally effective biologically active peptide or protein composition, method for the production thereof, and a pharmaceutical composition containing same
10/22/1986	EP0198386A2 Sustained high-level production of recombinant human gamma interferon using a bovine papillomavirus vector
10/22/1986	EP0198328A2 Vaccinia DNA
10/22/1986	EP0198271A2 Peptides
10/22/1986	EP0198259A1 Method for the immunological determination of heparan sulphate proteoglycan, and method for the extraction or purification of heparan sulphate proteoglycan suited therefor from or of tissues containing basal membranes
10/22/1986	EP0198039A1 $i(AOTUS) INTERSPECIES HYBRIDOMAS AND MONOCLONAL RECEPTORS PRODUCED THEREBY
10/22/1986	EP0198014A1 Vectors containing a gene for a protein having erythroid-potentiating activity and recombinant dna methods for producing said protein
10/22/1986	EP0197974A1 Acino-foetal differentiation proteins associated to the pancreas cancer, antiserum and monoclonal antibodies to said proteins, preparation methods
10/21/1986	US4618708 Enkephalinase inhibitor, analgesics, antidepressant, antidiarrhea, or hypotensive agent
10/21/1986	US4618600 Auriculin or analogs
10/21/1986	US4618578 Expression of glycoprotein D of herpes simplex virus
10/21/1986	US4618492 Crosslinking agents that permit controlled release of amino-group-containing substances under mildly acidic conditions
10/21/1986	CA1212915A1 Process for the preparation of hybrid human leukocyte interferons
10/15/1986	EP0197901A1 Biologically active fragments of the human antihemophilic factor and method for their preparation and pharmaceutical preparations
10/15/1986	EP0197798A2 Peptides
10/15/1986	EP0197797A2 Improved recombinant hosts, their production and use
10/15/1986	EP0197794A2 Preparation of peptides with C-terminal proline amide
10/15/1986	EP0197784A1 Method for immobilizing a biological material
10/15/1986	EP0197772A2 Peptides useful in vaccination against enteroviruses
10/15/1986	EP0197765A2 Purifying growth hormone-like materials
10/15/1986	EP0197764A2 Purifying proinsulin-like materials
10/15/1986	EP0197592A1 Preparation of the human von Willebrand factor by recombinant DNA
10/15/1986	EP0197558A2 Process for production of somatostatin
10/15/1986	EP0197554A2 Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
10/15/1986	EP0197510A2 A surfactant composed of acylated collagen or acylated gelatin and a production process thereof
10/15/1986	EP0197435A2 Choriocarcinoma monoclonal antibodies and antibody panels
10/15/1986	EP0197149A1 Method of obtaining human leukocytic interferon
10/15/1986	EP0197088A1 Hollow porous microsphere bioreactors and biochemical processes using same
10/15/1986	EP0197062A1 Anti-leishmania monoclonal antibodies, hybridomas secreting said antibodies, antigens of leishmania recognized by said antibodies, method for obtaining them and applications of said monoclonal antibodies and said antigens.
10/15/1986	EP0197059A1 Pharmacologically active peptide
10/15/1986	CN86101798A Process for the extraction and purification of proteins from culture media producing them
10/14/1986	US4617384 Adaptor molecules for DNA and their application to synthesis of gene-derived products
10/14/1986	US4617378 Purification of biologically active human immune interferon
10/14/1986	US4617376 Process for recovering glucagon from pancreas glands

1 ... 2860 2861 2862 2863 2864 2865 2866 2867 2868 2869 2870 2871 2872 2873 2874 2875 2876 2877 2878 2879 2880 ... 2916